A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee
Clinical trial NCT03754049 · COMPLETED
Trial details
- NCT number
- NCT03754049
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2023-11-07
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.